肺癌CT筛查项目中囊性肺病变的恶性风险
本回顾性研究纳入2015年1月至2023年7月大型医疗网络内所有CT肺癌筛查检查,共15762例患者中235例检出囊性肺病变,其中33例(14%)诊断为起源于囊性病变的肺癌。壁结节样增厚(OR 11,P=0.002)及实性结节(OR 5.3,P<0.001)单独或合并磨玻璃成分(OR 24,P<0.001)与癌症风险升高相关;无壁增厚的单房囊性病变(n=46)无恶性肿瘤病例。病变生长或复杂性增加与恶性风险升高相关(P<0.001),中位生长时间636天,中位癌症诊断时间482天,28例(85%)癌症为0期或I期。
要点
- 囊性肺病变伴壁结节样增厚者恶性风险升高(OR 11,P=0.002)。
- 无壁增厚的单房囊性病变(n=46)未见恶性肿瘤病例。
- 病变生长或复杂性增加与恶性风险升高相关(P<0.001)。
核心结论
- 伴壁结节样增厚的囊性肺病变恶性风险升高,而无壁增厚的单房病变基本无恶性风险。
- 多数恶性囊性肺病变呈惰性行为,生长缓慢且诊断时多为早期。
研究设计与样本
- 回顾性研究,纳入2015年1月至2023年7月大型医疗网络内所有CT肺癌筛查检查。
- 共15762例患者,其中235例检出囊性肺病变。
- 回顾基线CT记录病变形态特征和大小,所有随访CT评估病变变化。
- 采用Kaplan-Meier曲线分析生长风险和癌症诊断风险随时间的变化。
关键影像表现/征象
- 壁结节样增厚与癌症风险升高相关(OR 11,P=0.002)。
- 实性结节与癌症风险升高相关(OR 5.3,P<0.001),实性结节合并磨玻璃成分风险更高(OR 24,P<0.001)。
- 多房性与癌症风险升高无显著相关(OR 1.7,P>0.2)。
- 病变生长或复杂性增加与恶性风险升高相关(P<0.001)。
- 无壁增厚的单房囊性病变(n=46)无恶性肿瘤病例。
诊断标准与关键数值
- 壁结节样增厚:OR 11(P=0.002)。
- 实性结节:OR 5.3(P<0.001)。
- 实性结节合并磨玻璃成分:OR 24(P<0.001)。
- 多房性:OR 1.7(P>0.2)。
- 中位病变生长时间636天,中位癌症诊断时间482天,28例(85%)癌症为0期或I期。
临床应用与阅片要点
- 囊性肺病变伴壁结节样增厚者恶性风险升高,无壁增厚的单房病变基本无恶性风险。
- 实性结节合并磨玻璃成分者恶性风险更高(OR 24,P<0.001)。
- 随访中病变生长或复杂性增加提示恶性风险升高(P<0.001)。
- 多数恶性囊性肺病变生长缓慢且诊断时为早期(28例,85%为0期或I期)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background There is currently a lack of consensus regarding the risk of malignancy and the natural history of cystic lung lesions. Purpose To evaluate imaging characteristics associated with the risk of malignancy of cystic lung lesions in a lung cancer screening program. Materials and Methods This retrospective study included all CT lung cancer screening examinations performed from January 2015 to July 2023 in a large health care network. Radiology reports were queried for cystic lesions. Baseline CT images were reviewed, and lesion morphologic characteristics and size were recorded. All follow-up CT scans were evaluated for changes in the lesion. The risk of growth and diagnosis of cancer over time were analyzed with Kaplan-Meier curves. Results Among 15 762 patients, 235 were found to have cystic lung lesions; 33 (14%) of these patients were diagnosed with lung cancer arising from the cystic lesion. Increased risk of cancer was associated with nodular wall thickening (odds ratio [OR], 11; P = .002) and presence of a solid nodule (OR, 5.3; P < .001) alone or in combination with a ground-glass component (OR, 24; P < .001). Multilocularity was not associated with an increased risk of cancer (OR, 1.7; P > .2). There were no cases of malignancy in unilocular cystic lesions without wall thickening (n = 46). Lesion growth or increase in complexity over time was associated with an increased risk of malignancy (P < .001). The median time to lesion growth was 636 days. The median time to cancer diagnosis was 482 days, and 28 (85%) of the cancers were stage 0 or I. Conclusion Cystic lung lesions with nodular wall thickening had an increased risk of malignancy. Conversely, unilocular lesions without wall thickening had essentially no risk of malignancy. Most malignant cystic lung lesions exhibited indolent behavior, with slow growth and diagnosis at early stages. © RSNA, 2025 Supplemental material is available for this article. See also the editorial by Zagurovskaya in this issue.
引用
- Byrne SC, Hunsaker AR, Hammer MM, et al. Risk of Malignancy in Cystic Lung Lesions in a Lung Cancer CT Screening Program. Radiology. 2025. PMID: 40392085. doi:10.1148/radiol.243166
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。